Abstract
Efficacy and Safety of GR1802 in Patients With Moderate‐to‐Severe Atopic Dermatitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Phase 2 Trial
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have